May 27, 2021

EuropaBio welcomes the EU strategy on Covid-19 therapeutics

May 27, 2021

EuropaBio meets EMA to exchange views on topics of common interest

2021_05_H_O_EMA-EuropaBio bilateral meeting_Agenda items 1 & 2 2021_05_H_O_EMA-EuropaBio bilateral meeting_Agenda items 4 & 5
May 20, 2021

EuropaBio Patient BioForum: Advancing Patient Access to Innovative Treatments

May 7, 2021

IP waiver for COVID-19 vaccines is a misguided and ineffective response to a shared global challenge

2021_05_H_PR_Waiver of Intellectual Property Rights for COVID-19 Vaccines – EuropaBio’s Position
Become a member